Ablation of AMP-activated Protein Kinase Alpha1 and Alpha2 from Mouse Pancreatic Beta Cells and RIP2.Cre Neurons Suppresses Insulin Release in Vivo

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2010 Mar 12

PMID 20221584

Citations 52

Authors

G Sun

A I Tarasov

J McGinty

A McDonald

G da Silva Xavier

T Gorman

A Marley

P M French

H Parker

F Gribble

F Reimann

O Prendiville

R Carzaniga

B Viollet

I Leclerc

G A Rutter

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: AMP-activated protein kinase (AMPK) is an evolutionarily conserved enzyme and a target of glucose-lowering agents, including metformin. However, the precise role or roles of the enzyme in controlling insulin secretion remain uncertain.

Methods: The catalytic alpha1 and alpha2 subunits of AMPK were ablated selectively in mouse pancreatic beta cells and hypothalamic neurons by breeding Ampkalpha1 [also known as Prkaa1]-knockout mice, bearing floxed Ampkalpha2 [also known as Prkaa2] alleles (Ampkalpha1 ( -/- ),alpha2( fl/fl ),), with mice expressing Cre recombinase under the rat insulin promoter (RIP2). RIP2 was used to express constitutively activated AMPK selectively in beta cells in transgenic mice. Food intake, body weight and urinary catecholamines were measured using metabolic cages. Glucose and insulin tolerance were determined after intraperitoneal injection. Beta cell mass and morphology were analysed by optical projection tomography and confocal immunofluorescence microscopy, respectively. Granule docking, insulin secretion, membrane potential and intracellular free Ca(2+) were measured with standard techniques.

Results: Trigenic Ampkalpha1 ( -/- ),alpha2( fl/fl ) expressing Cre recombinase and lacking both AMPKalpha subunits in the beta cell, displayed normal body weight and increased insulin sensitivity, but were profoundly insulin-deficient. Secreted catecholamine levels were unchanged. Total beta cell mass was unaltered, while mean islet and beta cell volume were reduced. AMPK-deficient beta cells displayed normal glucose-induced changes in membrane potential and intracellular free Ca(2+), while granule docking and insulin secretion were enhanced. Conversely, betaAMPK transgenic mice were glucose-intolerant and displayed defective insulin secretion.

Conclusions/interpretation: Inhibition of AMPK activity within the beta cell is necessary, but not sufficient for stimulation of insulin secretion by glucose to occur. AMPK activation in extrapancreatic RIP2.Cre-expressing cells might also influence insulin secretion in vivo.

Citing Articles

Autophagy inhibits nuclear factor kappa B and mitogen-activated protein kinase (MAPK) inflammatory signaling pathways and modulates cytokine release in murine microglia following Streptococcus suis serotype 2 infection.

Xiao H, Ji H, Zhou N, Xiao Y, Shi D J Vet Med Sci. 2024; 87(1):68-74.

PMID: 39603605 PMC: 11735217. DOI: 10.1292/jvms.24-0203.

Liver kinase B1 (LKB1) regulates the epigenetic landscape of mouse pancreatic beta cells.

Haberman N, Cheung R, Pizza G, Cvetesic N, Nagy D, Maude H FASEB J. 2024; 38(16):e23885.

PMID: 39139039 PMC: 11378476. DOI: 10.1096/fj.202401078R.

Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes.

Rivera Nieves A, Wauford B, Fu A Front Mol Biosci. 2024; 11:1354199.

PMID: 38404962 PMC: 10884328. DOI: 10.3389/fmolb.2024.1354199.

Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase.

Nguyen-Tu M, Harris J, Martinez-Sanchez A, Chabosseau P, Hu M, Georgiadou E Diabetologia. 2022; 65(6):997-1011.

PMID: 35294578 PMC: 9076735. DOI: 10.1007/s00125-022-05673-x.

Brain Permeable AMP-Activated Protein Kinase Activator R481 Raises Glycaemia by Autonomic Nervous System Activation and Amplifies the Counterregulatory Response to Hypoglycaemia in Rats.

Cruz A, Partridge K, Malekizadeh Y, Vlachaki Walker J, Potter P, Pye K Front Endocrinol (Lausanne). 2022; 12:697445.

PMID: 34975743 PMC: 8718766. DOI: 10.3389/fendo.2021.697445.

References

Jones R, Plas D, Kubek S, Buzzai M, Mu J, Xu Y . AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005; 18(3):283-93. DOI: 10.1016/j.molcel.2005.03.027. View

Viollet B, Andreelli F, Jorgensen S, Perrin C, Flamez D, Mu J . Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans. 2003; 31(Pt 1):216-9. DOI: 10.1042/bst0310216. View

Leclerc I, Woltersdorf W, da Silva Xavier G, Rowe R, Cross S, Korbutt G . Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2004; 286(6):E1023-31. DOI: 10.1152/ajpendo.00532.2003. View

Long Y, Zierath J . AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006; 116(7):1776-83. PMC: 1483147. DOI: 10.1172/JCI29044. View

Gleason C, Lu D, Witters L, Newgard C, Birnbaum M . The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. J Biol Chem. 2007; 282(14):10341-51. DOI: 10.1074/jbc.M610631200. View

Hardie D, Carling D . The AMP-activated protein kinase--fuel gauge of the mammalian cell?. Eur J Biochem. 1997; 246(2):259-73. DOI: 10.1111/j.1432-1033.1997.00259.x. View

Targonsky E, Dai F, Koshkin V, Karaman G, Gyulkhandanyan A, Zhang Y . alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Diabetologia. 2006; 49(7):1587-98. DOI: 10.1007/s00125-006-0265-9. View

Canabal D, Song Z, Potian J, Beuve A, McArdle J, Routh V . Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2006; 292(4):R1418-28. DOI: 10.1152/ajpregu.00216.2006. View

McCrimmon R, Fan X, Cheng H, McNay E, Chan O, Shaw M . Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes. 2006; 55(6):1755-60. DOI: 10.2337/db05-1359. View

10.

da Silva Xavier G, Leclerc I, Varadi A, Tsuboi T, Moule S, Rutter G . Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J. 2003; 371(Pt 3):761-74. PMC: 1223356. DOI: 10.1042/BJ20021812. View

11.

Kefas B, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D . AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol. 2003; 30(2):151-61. DOI: 10.1677/jme.0.0300151. View

12.

Fu A, Ng A, Depatie C, Wijesekara N, He Y, Wang G . Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. Cell Metab. 2009; 10(4):285-95. DOI: 10.1016/j.cmet.2009.08.008. View

13.

Granot Z, Swisa A, Magenheim J, Stolovich-Rain M, Fujimoto W, Manduchi E . LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab. 2009; 10(4):296-308. PMC: 2790403. DOI: 10.1016/j.cmet.2009.08.010. View

14.

Choudhury A, Heffron H, Smith M, Al-Qassab H, Xu A, Selman C . The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest. 2005; 115(4):940-50. PMC: 1069106. DOI: 10.1172/JCI24445. View

15.

Rahier J, Goebbels R, Henquin J . Cellular composition of the human diabetic pancreas. Diabetologia. 1983; 24(5):366-71. DOI: 10.1007/BF00251826. View

16.

Minokoshi Y, Alquier T, Furukawa N, Kim Y, Lee A, Xue B . AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004; 428(6982):569-74. DOI: 10.1038/nature02440. View

17.

Wyatt C, Mustard K, Pearson S, Dallas M, Atkinson L, Kumar P . AMP-activated protein kinase mediates carotid body excitation by hypoxia. J Biol Chem. 2006; 282(11):8092-8. PMC: 1832262. DOI: 10.1074/jbc.M608742200. View

18.

Viollet B, Andreelli F, Jorgensen S, Perrin C, Geloen A, Flamez D . The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest. 2003; 111(1):91-8. PMC: 151837. DOI: 10.1172/JCI16567. View

19.

Richards S, Parton L, Leclerc I, Rutter G, Smith R . Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo. J Endocrinol. 2005; 187(2):225-35. DOI: 10.1677/joe.1.06413. View

20.

Kalra S . Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches. Nutrition. 2008; 24(9):820-6. PMC: 2568986. DOI: 10.1016/j.nut.2008.06.023. View